JNJ vs V: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Johnson & Johnson · Healthcare
$238.46
-11.8% upside to fair value
Med Conviction
Grade C+
VS
Visa Inc. · Financial Services
$304.36
+37.7% upside to fair value
High Conviction
Grade A-
QuantHub Verdict
V has more upside to fair value
(+37.7%).
JNJ trades at a lower forward P/E
(20.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
V |
| Current Price |
$238.46 |
$304.36 |
| Fair Value Estimate |
$210.28 |
$419.00 |
| Upside to Fair Value |
-11.8%
|
+37.7%
|
| Market Cap |
$574.7B |
$586.8B |
| Forward P/E |
20.2x
|
23.7x
|
| EV / EBITDA |
13.3x
|
22.3x
|
| Price / Sales |
6.2x
|
14.2x
|
| Price / FCF |
29.4x
|
25.6x
|
| Revenue Growth YoY |
+6.1%
|
+11.3%
|
| Gross Margin |
72.8%
|
81.08%
|
| Operating Margin |
27.2%
|
59.18%
|
| Return on Equity |
32.87%
|
54.22%
|
| Dividend Yield |
2.18% |
0.83% |
| FCF Yield |
3.4%
|
3.91%
|
| Analyst Consensus |
Moderate Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a high-quality healthcare conglomerate focused exclusively on Innovative Medicine and MedTech following the Kenvue spin-off. The company delivered $94.2B in FY2025 revenue with 6% operational growth, generated $19.7B in free cash flow, and guided for $99.5-100.5B in 2026 operational sales (above consensus). However, at $238 the stock trades at a P/S of 6.15x, well above the 5…
Visa is the world's dominant payment network with $40B in net revenue (FY2025), 50%+ net margins, and a capital-light toll-booth model processing $14.2T in annual payment volume across 257.5B transactions. The business compounds at 10-12% revenue CAGR with operating leverage pushing EPS growth to 12-15% over a cycle, funded by $21.6B in annual free cash flow against only $1.5B in capex. At 28.0x …
Accumulation Zones
| Metric |
JNJ |
V |
| Zone Low |
$157.71 |
$265.00 |
| Zone High |
$178.74 |
$300.00 |
| In Buy Zone? |
No
|
No
|